SPC99
Úmeklidíníum brómíð
Status:
VeittApplication date:
2.10.2014Application published:
15.10.2014Grant published:
15.7.2015
Max expiry date:
29.4.2029Next due date:
30.4.2026Medicine name:
IncruseMedicine for children:
No
Timeline
Today
2.10.2014Application
15.10.2014Publication
15.7.2015Registration
26.4.2026Expires
Marketing license
IS authorization number:
EU/1/14/922/001-003Date:
22.5.2014
Foreign authorization number:
EU/1/14/922/001-003Date:
28.4.2014
Owner
Name:
GLAXO GROUP LIMITEDAddress:
GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP1740177
Annual fees
Number
Paid
Expires
Payer
Number: 1
Paid: 11.4.2025
Expires: 26.4.2026
Payer: Árnason Faktor ehf.